Breaking News

Quotient Sciences Expands UK Footprint

Acquires UK-based CDMO Pharmaterials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Drug development services organization Quotient Sciences has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, UK. The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the UK, and further supports the growth of Quotient’s Translational Pharmaceutics platform, following the acquisitions of SeaView Research and QS Pharma in February 2017. Pharmaterials has a significant track record in support...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters